Effect of Preoperative Rehabilitation Exercise on Improving Postoperative Lymphedema, Quality of Life and Care Needs in Patients With Breast Cancer Surgery
Breast cancer is one of the most common cancers among women worldwide, with surgery being a primary treatment. However, surgical tumor resection combined with lymph node dissection often leads to upper extremity lymphedema as a complication. This study aims to evaluate the effectiveness of preoperative rehabilitation exercise on upper limb function, lymphedema severity, quality of life, and post-discharge care needs in breast cancer patients undergoing surgery. Participants will be assigned to either an…
Conditions studied
Breast Cancer and Rehabilitation
About this study
Breast cancer is one of the most common cancers among women worldwide, with surgery being a primary treatment. However, surgical tumor resection combined with lymph node dissection often leads to upper extremity lymphedema as a complication. This study aims to evaluate the effectiveness of preoperative rehabilitation exercise on upper limb function, lymphedema severity, quality of life, and post-discharge care needs in breast cancer patients undergoing surgery. Participants will be assigned to either an experimental group receiving individualized preoperative rehabilitation exercise instruction or a control group receiving standard clinical nursing education. Outcomes will be measured across seven time points from pre-operation up to one year post-surgery.
Interventions
- Behavioral: Preoperative Upper Limb Rehabilitation Exercise — Individualized instruction and guidance on upper limb rehabilitation exercises starting 1 day prior to surgery to reduce postoperative lymphedema and improve physical function.
- Other: Standard Nursing Care and Education — Routine clinical nursing education executed preoperatively or on postoperative Day 1 according to standard ward procedures.
Primary outcomes
- Postoperative Upper Extremity Lymphedema Severity (Arm Circumference) (Baseline (1 day pre-operation), Postoperative Day 1, Week 2, Week 4, Month 3, Month 6, and Year 1)
Eligibility information
Study locations
- National Taiwan University Hospital Cancer Center, Taipei, 106 Taiwan
- National Taiwan University Hospital, Taipei, Taiwan
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.